High quality raw material for IVD manufacturing industry

Recombinant Spike S1 (C-term) antigen (S1-CTD) for SARS-CoV (2003)

RekomBiotech
SARS-CoV (2003)

S1 (CTD) is a C-terminal recombinant region of spike glycoprotein S1 ectodomain for SARS-CoV detection. The spike (S) protein is a surface trimer glycoprotein located on the envelope of the virions. It is cleaved into S1 and S2 subunits. The S1 subunit is responsible for host-receptor binding while the S2 subunit contains the membrane-fusion machinery. There are two domains in coronavirus S1, N-terminal domain (S1-NTD) and C-terminal domain (S1-CTD). One or both of these S1 domains potentially bind receptors and function as the receptor-binding domain (RBD).

View more information about Severe acute respiratory syndrome (SARS).

REFERENCES
RAG0076 new WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
GENE
S
DESCRIPTION
Ectodomain S1 (C-term) (S1-CTD) of the spinal surface glycoprotein (S)
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped with dry ice or lyophilized. Upon arrival (if liquid), or after reconstitution (if lyophilized), they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
Not tested. According to the literature, the protein is immunoreactive against seropositive individuals to Severe acute respiratory syndrome (SARS)
IVD
SARS-CoV serodiagnosis
PROMOTIONAL MATERIAL
RELATED PRODUCTS

FOR RESEARCH AND COMERCIAL USE IVD ONLY (*)

(*) Our antigens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our antigens, you can visit here.

RETURN TO HUMAN RECOMBINANT ANTIGENS